Global Biophotonics Market - Segmented by Technology and Geography - Growth, Trends, and Forecast (2022 - 2030)
The biophotonics market is expected to witness a CAGR of 11.2% during the forecast period( 2018-2023). The United States holds the largest share in the biophotonics market, in the year 2015.
Rising of the Aging Population
The worldwide biophotonics market is expected to witness a significant growth in the future, due to the rising old age population, along with the increasing incidence of chronic diseases. It is estimated that approximately 90% of the aged adults have at least one chronic disease. People of age 55 years, or above, are prone to the various chronic diseases, such as cardiovascular diseases, infectious diseases, cancer, and diabetes, and due to the rising old age population, the use of this technology is also rising, which is fueling the market for biophotonics.
The other factors include, increasing use of biophotonics in cell and tissue diagnostics, emergence of nanotechnology in biophotonics, and development of novel
photoacoustic tomography (PAT) system.
High Cost of the Technology acts as Barrier
The usage of new technologies and the latest advancements in the field of the laser devices and LED’s is increasing the cost of the technology. The development in sensors and other accessories that are being required in biophotonics-based instruments are leading to a high cost, which acts as a barrier for the market. Some of the pptical coherence tomography (OCT) systems are being priced, which are usually beyond the reach of most of the users. The high cost associated with the technology is restraining the growth of the market.
The other factor that is also responsible for restraining the market, is the lack of awareness of biophotonics technology and skilled personnel.
North America Dominates the Biophotonics Market
North America is a major market in the biophotonics industry, and this is mainly due to the US government’s initiatives taken to develop this market. The United States had the largest biophotonics market in 2015. Also, the emergence of nanotechnology has driven the biophotonics market in the United States and is expected to grow in the near future. Moreover, the high investments that are being taken in the healthcare industry and growing R&D initiatives are further expected to drive the market in this region. Europe, along with APAC, is also expected to witness a significant growth in the years to come.
Key Developments in the Market
• December 2017: Thermo Fisher Scientific completed acquisition of Phenom-World, which strengthens Thermo Fisher's leadership in electron microscopy
• September 2017: Olympus Corporation launches the ORBEYE surgical microscope with 4K 3D capabilities supporting precision surgery, with high-resolution digital images and stereoscopic visual field
Major Players: THERMO FISHER SCIENTIFIC INC., NU SKIN ENTERPRISES, BECTON DICKINSON & CO., GLENBROOK TECHNOLOGIES, HAMAMATSU PHOTONICS KK, OLYMPUS CORPORATION, CARL ZEISS AG, OXFORD INSTRUMENTS PLC, AND ZENALUX BIOMEDICAL INC. amongst others.
Reasons to Purchase the Report
• Current and future market outlook for biophotonics in the developed and emerging markets
• Analyze various perspectives on the market, with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth, during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the market estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
Rising of the Aging Population
The worldwide biophotonics market is expected to witness a significant growth in the future, due to the rising old age population, along with the increasing incidence of chronic diseases. It is estimated that approximately 90% of the aged adults have at least one chronic disease. People of age 55 years, or above, are prone to the various chronic diseases, such as cardiovascular diseases, infectious diseases, cancer, and diabetes, and due to the rising old age population, the use of this technology is also rising, which is fueling the market for biophotonics.
The other factors include, increasing use of biophotonics in cell and tissue diagnostics, emergence of nanotechnology in biophotonics, and development of novel
photoacoustic tomography (PAT) system.
High Cost of the Technology acts as Barrier
The usage of new technologies and the latest advancements in the field of the laser devices and LED’s is increasing the cost of the technology. The development in sensors and other accessories that are being required in biophotonics-based instruments are leading to a high cost, which acts as a barrier for the market. Some of the pptical coherence tomography (OCT) systems are being priced, which are usually beyond the reach of most of the users. The high cost associated with the technology is restraining the growth of the market.
The other factor that is also responsible for restraining the market, is the lack of awareness of biophotonics technology and skilled personnel.
North America Dominates the Biophotonics Market
North America is a major market in the biophotonics industry, and this is mainly due to the US government’s initiatives taken to develop this market. The United States had the largest biophotonics market in 2015. Also, the emergence of nanotechnology has driven the biophotonics market in the United States and is expected to grow in the near future. Moreover, the high investments that are being taken in the healthcare industry and growing R&D initiatives are further expected to drive the market in this region. Europe, along with APAC, is also expected to witness a significant growth in the years to come.
Key Developments in the Market
• December 2017: Thermo Fisher Scientific completed acquisition of Phenom-World, which strengthens Thermo Fisher's leadership in electron microscopy
• September 2017: Olympus Corporation launches the ORBEYE surgical microscope with 4K 3D capabilities supporting precision surgery, with high-resolution digital images and stereoscopic visual field
Major Players: THERMO FISHER SCIENTIFIC INC., NU SKIN ENTERPRISES, BECTON DICKINSON & CO., GLENBROOK TECHNOLOGIES, HAMAMATSU PHOTONICS KK, OLYMPUS CORPORATION, CARL ZEISS AG, OXFORD INSTRUMENTS PLC, AND ZENALUX BIOMEDICAL INC. amongst others.
Reasons to Purchase the Report
• Current and future market outlook for biophotonics in the developed and emerging markets
• Analyze various perspectives on the market, with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth, during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the market estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
